Abstract:In malaria-naïve individuals, Plasmodium falciparum infection results in high levels of parasite-infected red blood cells (iRBCs) that trigger systemic inflammation and fever. Conversely, individuals in endemic areas who are repeatedly infected are often asymptomatic and have low levels of iRBCs, even young children. We hypothesized that febrile malaria alters the immune system such that P. falciparum re-exposure results in reduced production of pro-inflammatory cytokines/chemokines and enhanced anti-parasite effector responses compared to responses induced before malaria. To test this hypothesis we used a systems biology approach to analyze PBMCs sampled from healthy children before the six-month malaria season and the same children seven days after treatment of their first febrile malaria episode of the ensuing season. PBMCs were stimulated with iRBC in vitro and various immune parameters were measured. Before the malaria season, children's immune cells responded to iRBCs by producing pro-inflammatory mediators such as IL-1β, IL-6 and IL-8. Following malaria there was a marked shift in the response to iRBCs with the same children's immune cells producing lower levels of pro-inflammatory cytokines and higher levels of anti-inflammatory cytokines (IL-10, TGF-β). In addition, molecules involved in phagocytosis and activation of adaptive immunity were upregulated after malaria as compared to before. This shift was accompanied by an increase in P. falciparum-specific CD4+Foxp3- T cells that co-produce IL-10, IFN-γ and TNF; however, after the subsequent six-month dry season, a period of markedly reduced malaria transmission, P. falciparum-inducible IL-10 production remained partially upregulated only in children with persistent asymptomatic infections. These findings suggest that in the face of P. falciparum re-exposure, children acquire exposure-dependent P. falciparum-specific immunoregulatory responses that dampen pathogenic inflammation while enhancing anti-parasite effector mechanisms. These data provide mechanistic insight into the observation that P. falciparum-infected children in endemic areas are often afebrile and tend to control parasite replication.

Chloroquine treatment influences immunological memory through the PD-1/PD-L1 pathway during the initiation of Plasmodium chabaudi infection

Plasmodium Falciparum Malaria in the Peruvian Amazon, a Region of Low Transmission, is Associated with Immunologic Memory

A Positive Correlation Between Atypical Memory B Cells and Plasmodium Falciparum Transmission Intensity in Cross-Sectional Studies in Peru and Mali

A Molecular Signature in Blood Reveals a Role for P53 in Regulating Malaria-Induced Inflammation.

Autoantibodies Inhibit Plasmodium Falciparum Growth and Are Associated with Protection from Clinical Malaria

The Plasmodium Falciparum-Specific Human Memory B Cell Compartment Expands Gradually with Repeated Malaria Infections.

Treatment of Chronic Asymptomatic Plasmodium Falciparum Infection Does Not Increase the Risk of Clinical Malaria Upon Reinfection

Exposure-Dependent Control of Malaria-Induced Inflammation in Children

PD-1 Blockade Promotes Immune Memory Following Plasmodium Berghei ANKA Reinfection

High efficiency human memory B cell assay and its application to studying Plasmodium falciparum-specific memory B cells in natural infections.

Repeated Malaria Exposures Associate with Skewing of Monocytes/macrophages Toward a Regulatory Phenotype

The CTLA-4 and PD-1/PD-L1 Inhibitory Pathways Independently Regulate Host Resistance to Plasmodium-induced Acute Immune Pathology

Toll-like Receptor 4, Toll-like Receptor 7 and Toll-like Receptor 9 Agonists Enhance Immune Responses Against Blood-Stage Plasmodium Chabaudi Infection in BALB/c Mice.

IL-27 produced during acute malaria infection regulates Plasmodium-specific memory CD4+ T cells

Malaria-associated atypical memory B cells exhibit markedly reduced B cell receptor signaling and effector function.

Toll-like Receptor 7 and Toll-like Receptor 9 Agonists Effectively Enhance Immunological Memory in Plasmodium Chabaudi Infected BALB/c Mice

Regulation of the CD8+ T cell responses against Plasmodium liver stages in mice

Co-administration of chloroquine and coenzyme Q10 improved treatment outcome during experimental cerebral malaria

Plasmodium yoelii Infection Enhances the Expansion of Myeloid-Derived Suppressor Cells via JAK/STAT3 Pathway

DC-Derived IL-10 Modulates Pro-inflammatory Cytokine Production and Promotes Induction of CD4+IL-10+ Regulatory T Cells during Plasmodium yoelii Infection

Memory CD8+ T cell‐mediated protection against liver‐stage malaria